Stockreport

Galectin: Q4 2024 NASH Cirrhosis Data Readout Is A Major Inflection Point [Seeking Alpha]

Galectin Therapeutics Inc.  (GALT) 
Last galectin therapeutics inc. earnings: 11/12 08:00 am Check Earnings Report
PDF In a prior phase 2 study, it was shown that Belapectin was effective in treating patients who had not yet developed esophageal varices. Global non-alcoholic steatohep [Read more]